Cannabinoids for Chronic Pain
- PMID: 38620539
- Bookshelf ID: NBK598491
Cannabinoids for Chronic Pain
Excerpt
Therapeutics Letter 115 examines cannabinoids for chronic pain. Conclusions: Health care providers need to be knowledgeable and non-judgmental when informing patients about cannabinoids. The complexity of cannabinoids as a therapy makes research particularly difficult. At the present time we lack good evidence that any cannabis-derived product works for chronic pain. Future trials need to use fixed dose product composition and assess real world benefits and harms over suitably long durations.
Copyright © 1994 - 2022 Therapeutics Initiative, University of British Columbia.
Sections
References
-
- Government of Canada. Cannabis, Licensed Producers, Market Data 2018. September 28, 2018. https://canada.ca/en/health-canada/services/drugs-medication/cannabis/li... [Accessed 20 Nov 2018]
-
- Rotermann M, Page MM. Prevalence and correlates of non-medical only compared to self-defined medical and non-medical cannabis use, Canada, 2015. Health Reports. 2018; 29(7):3–13. http://web.a.ebscohost.com/ehost/pdfviewer/pdfviewer?vid=1&sid=c4137e02-... [Accessed 20 Nov 2018] - PubMed
-
- College of Physicians and Surgeons of British Columbia. Practice Standard. Cannabis for Medical Purposes. 2018. https://cpsbc.ca/files/pdf/PSG-Cannabis-for-Medical-Purposes.pdf [Accessed 20 Nov 2018]
-
- Grinspoon P. Medical marijuana. Harvard Health Blog [Internet]. 2018. https://www.health.harvard.edu/blog/medical-marijuana-2018011513085 [Accessed 20 Nov 2018]
-
- GW Pharma Ltd. Product Monograph - Sativex 2012. https://pdf.hres.ca/dpd_pm/00016162.PDF [Accessed 20 Nov 2018]
Publication types
LinkOut - more resources
Full Text Sources